Google Translate Limitations Disclaimer

The electronic translation service on the brainXchange website is hosted by Google Translate, an external translation service. The brainXchange does not guarantee or warrant the reliability, accuracy or completeness of any translated information. The basic translation goal is to capture the general information of the original English website content. If any questions arise related to the accuracy of the information contained in the translated website, please refer to the English version of the website.

Home > Events > Archived Webinars & Events > 2021 > Non-cognitive markers of Dementia: There is something in the way you walk

Non-cognitive markers of Dementia: There is something in the way you walk

Event Date: Mar 25, 2021

Related Resources l Recording

Cognitive impairment is the hallmark of Alzheimer’s disease (AD) and related dementias. However, motor decline, specifically slowing speed in the way we walk, has been recently described as a prodromal state that can help to detect at-risk individuals. Similarly, hearing changes, sleep and behavior disturbances have been associated with higher risk of developing dementia. These clinical findings, together with the recognition that AD pathology precedes the diagnosis by many years, raises the possibility that non-cognitive changes may be early and non-invasive markers for AD or, even more provocatively, that treating non-cognitive aspects may help to prevent or treat AD and related dementias.

This integrated KTE webinar event is brought to you by brainXchange in partnership with the Alzheimer Society of Canada and the Canadian Consortium of Neurodegeneration in Aging (CCNA).

Related Documents:

Presenter(s):

Manuel Montero-Odasso MD, PhD, FRCPC, AGSF, FGSA

Dr. Montero-Odasso is a Professor in the Departments of Medicine, and Epidemiology and Biostatistics at the University of Western Ontario and Director of the “Gait & Brain Lab” at Parkwood Institute, London, Ontario. He is a geriatrician and clinician-scientist at the Lawson Health Research Institute and serves as team leader at the Canadian Consortium on Neurodegeneration in Aging (CCNA) and team co-leader at the Ontario Neurodegenerative Research Initiative (ONDRI).

Dr. Montero-Odasso leads the Gait and Brain Health Program with the goal of understanding mechanisms and potential treatments of mobility and cognitive decline in older individuals. In addition, Dr. Montero-Odasso has created a successful research program while remaining an active clinician. His research has received uninterrupted peer-reviewed funding from national and international agencies, including the Canadian Institutes of Health and Research (CIHR).

He has published over 150 peer-reviewed articles in high-impact journals in aging and neurosciences and edited 2 books and 15 chapters on aging, mild cognitive impairment and Alzheimer’s disease and mobility and falls He has received several accolades and awards and serves as associate editor and board member of aging journals including, Journal of Alzheimer’s Disease, Geriatrics, and Journal of Gerontology Medical Sciences. He is a member of the advisory board for the Institute of Aging (CIHR), CIHR review committee member, and Secretary-Treasurer of the Canadian Geriatrics Society. He has delivered more than 100 international presentations as a guest or key-note speaker.